Protalix BioTherapeutics
PLX
#8757
Rank
ยฃ78.53 M
Marketcap
ยฃ1.07
Share price
9.27%
Change (1 day)
-2.86%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -ยฃ10.42 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are ยฃ38.05 Million. In 2023 the company made an earning of ยฃ9.26 Million, an increase over its 2022 earnings that were of -ยฃ9.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ10.42 Million-212.42%
2023 ยฃ9.26 M-199.05%
2022 -ยฃ9.36 Million-40.38%
2021 -ยฃ15.69 Million-732.31%
2020 ยฃ2.48 M-130.53%
2019 -ยฃ8.13 Million189.85%
2018 -ยฃ2.81 Million-95.29%
2017 -ยฃ59.55 Million308.12%
2016 -ยฃ14.59 Million-32.37%
2015 -ยฃ21.58 Million10.11%
2014 -ยฃ19.6 Million-7.59%
2013 -ยฃ21.2 Million
2011 -ยฃ24.55 Million-19.39%
2010 -ยฃ30.46 Million20.87%
2009 -ยฃ25.2 Million32.26%
2008 -ยฃ19.05 Million-5.46%
2007 -ยฃ20.15 Million
2004 -ยฃ0.14 Million12.35%
2003 -ยฃ0.12 Million-11.1%
2002 -ยฃ0.14 Million-57.03%
2001 -ยฃ0.31 Million1.03%
2000 -ยฃ0.31 Million-53.22%
1999 -ยฃ0.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ78.69 Million 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.51 B-5,090.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.96 Billion 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.65 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel